Molecular and biological markers of the urinary bladder superficial and invasive cancer

被引:0
作者
Prodanets, N. N. [1 ]
Snopova, L. B. [1 ]
Bunegina, L. V. [2 ]
机构
[1] Nizhny Novgorod State Med Acad, FM SRI CSRL, Morphol Dept, Nizhnii Novgorod, Russia
[2] NI Lobachevsky Nizhny Novgorod State Univ, Nizhnii Novgorod, Russia
关键词
molecular and biological markers; urinary bladder cancer;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The modern data on the molecular and genetic marker expression study in the urinary bladder tumors and their use in a differential diagnosis of the urinary bladder cancer is presented. It is demonstrated, that the morphological and molecular sign assessment of difference in a group of the urinary bladder noninvasive tumors is of greatest difficulty. The immunohistochemical and molecular absolute criteria of such difference are not yet described. Everything is solved in each certain case according to the aggregate of signs. It is possible to prognose a disease flow more precisely and timely correct a treatment only at a use of combination of several tissue markers with such well-known and widely used in practice prognostic factors, as a degree of tumoral invasion, multifocality of growth and a tumor anaplasia degree.
引用
收藏
页码:87 / 91
页数:5
相关论文
共 49 条
  • [1] Apoptosis in transitional cell carcinoma of bladder and its relation to proliferation and expression of P53 and Bcl-2
    Amirghofran, Z
    Monabati, A
    Khezri, A
    Malek-Hosseini, Z
    [J]. PATHOLOGY & ONCOLOGY RESEARCH, 2004, 10 (03) : 154 - 158
  • [2] Anton H.N, 2002, AM J PATHOL, P161
  • [3] APOLIHIN OI, 2007, PUTI ULUCHSHENIYA OB
  • [4] Muscle invasive schistosomal squamous cell carcinoma of the urinary bladder: Frequency and prognostic significance of p53, BCL-2, HER2/neu, and proliferation (MIB-1)
    Badr, KM
    Nolen, JDL
    Derose, PB
    Cohen, C
    [J]. HUMAN PATHOLOGY, 2004, 35 (02) : 184 - 189
  • [5] Atypia in inverted urothelial papillomas: Pathology and prognostic significance
    Broussard, JN
    Tan, PH
    Epstein, JI
    [J]. HUMAN PATHOLOGY, 2004, 35 (12) : 1499 - 1504
  • [6] Burchardt M, 2000, CLIN CHEM, V46, P595
  • [7] Loss of blood group A antigen expression in bladder cancer caused by allelic loss and/or methylation of the ABO gene (vol 85, pg 895, 2005)
    Chihara, Y
    Sugano, K
    Kobayashi, A
    Kanai, Y
    Yamamoto, H
    Nakazono, M
    Fujimoto, H
    Kakizoe, T
    Fujimoto, K
    Hirohashi, S
    Hirao, Y
    [J]. LABORATORY INVESTIGATION, 2005, 85 (08) : 1051 - 1051
  • [8] CORDONCARDO C, 1988, CANCER RES, V48, P4113
  • [9] Urinary markers of bladder carcinoma
    Dey, P
    [J]. CLINICA CHIMICA ACTA, 2004, 340 (1-2) : 57 - 65
  • [10] AN IMMUNOHISTOCHEMICAL AND PROGNOSTIC EVALUATION OF CATHEPSIN-D EXPRESSION IN 105 BLADDER CARCINOMAS
    DICKINSON, AJ
    FOX, SB
    NEWCOMB, PV
    PERSAD, RA
    SIBLEY, GN
    HARRIS, AL
    [J]. JOURNAL OF UROLOGY, 1995, 154 (01) : 237 - 241